BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Tucows
TCX
$157M
| $51.8M | ﹤0.01% |
645,074
-35,416
| -5% | -$2.81M |
|
|
FRTA
2677
DELISTED
Forterra, Inc
FRTA
| $51.8M | ﹤0.01% |
2,203,426
-147,339
| -6% | -$3.45M |
|
2678
Beazer Homes USA
BZH
$931M
| $51.7M | ﹤0.01% |
2,681,404
-100,945
| -4% | -$2.22M |
|
|
FFIC
2679
DELISTED
Flushing Financial
FFIC
| $51.7M | ﹤0.01% |
2,413,597
-254,596
| -10% | -$5.75M |
|
2680
Independent Bank Corp
IBCP
$791M
| $51.6M | ﹤0.01% |
2,376,323
-60,146
| -2% | -$1.39M |
|
|
SPYM
2681
State Street SPDR Portfolio S&P 500 ETF
SPYM
$167B
| $51.5M | ﹤0.01% |
1,023,939
+400,968
| +64% | +$19.7M |
|
|
CD
2682
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $51.4M | ﹤0.01% |
+3,408,186
| New | +$51.2M |
|
|
CPLG
2683
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $51.4M | ﹤0.01% |
4,801,802
+111,194
| +2% | +$1.12M |
|
2684
Latham Group
SWIM
$857M
| $51.2M | ﹤0.01% |
+1,603,482
| New | +$46.8M |
|
2685
SK Telecom
SKM
$13.4B
| $51.2M | ﹤0.01% |
990,177
-469,571
| -32% | -$23.9M |
|
|
RAPT
2686
DELISTED
RAPT Therapeutics
RAPT
| $51.1M | ﹤0.01% |
201,083
+27,173
| +16% | +$5.08M |
|
|
CLVS
2687
DELISTED
Clovis Oncology, Inc.
CLVS
| $51.1M | ﹤0.01% |
8,815,674
+996,664
| +13% | +$5.84M |
|
|
BNR
2688
Burning Rock Biotech
BNR
$93.7M
| $51.1M | ﹤0.01% |
+173,531
| New | +$51.3M |
|
|
TPC
2689
Tutor Perini Cor
TPC
$4.45B
| $51M | ﹤0.01% |
3,685,435
+68,483
| +2% | +$1.09M |
|
2690
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.7B
| $51M | ﹤0.01% |
1,290,450
-133,239
| -9% | -$5.27M |
|
2691
Stoke Therapeutics
STOK
$1.99B
| $51M | ﹤0.01% |
1,515,439
-144,673
| -9% | -$5.11M |
|
|
ATRS
2692
DELISTED
Antares Pharma, Inc.
ATRS
| $51M | ﹤0.01% |
11,688,169
-387,411
| -3% | -$1.58M |
|
2693
BrightView Holdings
BV
$988M
| $50.9M | ﹤0.01% |
3,159,854
-8,848
| -0.3% | -$155K |
|
|
XENT
2694
DELISTED
Intersect ENT, Inc
XENT
| $50.5M | ﹤0.01% |
2,956,338
-18,824
| -0.6% | -$352K |
|
2695
Matrix Service
MTRX
$325M
| $50.5M | ﹤0.01% |
4,809,247
+156,967
| +3% | +$1.89M |
|
2696
Shattuck Labs
STTK
$704M
| $50.5M | ﹤0.01% |
1,741,342
+857,444
| +97% | +$25.1M |
|
2697
Vera Bradley
VRA
$99.2M
| $50.4M | ﹤0.01% |
4,068,585
+116,907
| +3% | +$1.34M |
|
2698
CALL
Ralph Lauren
RL
$22.7B
| $50.4M | ﹤0.01% |
+427,500
| New | +$53.5M |
|
2699
Ribbon Communications
RBBN
$384M
| $50.1M | ﹤0.01% |
6,586,578
-145,601
| -2% | -$1.11M |
|
|
TTM
2700
DELISTED
Tata Motors Limited
TTM
| $50.1M | ﹤0.01% |
2,199,390
-236,891
| -10% | -$5.08M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.